These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 26485496)
1. Cross-validation of a Shortened Battery for the Assessment of Dysexecutive Disorders in Alzheimer Disease. Godefroy O; Martinaud O; Verny M; Mosca C; Lenoir H; Bretault E; Devendeville A; Diouf M; Pere JJ; Bakchine S; Delabrousse-Mayoux JP; Roussel M; Alzheimer Dis Assoc Disord; 2016; 30(2):140-4. PubMed ID: 26485496 [TBL] [Abstract][Full Text] [Related]
2. The dysexecutive syndrome of Alzheimer's disease: the GREFEX study. Godefroy O; Martinaud O; Verny M; Mosca C; Lenoir H; Bretault E; Roussel M J Alzheimers Dis; 2014; 42(4):1203-8. PubMed ID: 25024318 [TBL] [Abstract][Full Text] [Related]
3. Executive Functions Deficits After Severe Traumatic Brain Injury: The GREFEX Study. Azouvi P; Vallat-Azouvi C; Joseph PA; Meulemans T; Bertola C; Le Gall D; Bellmann A; Roussel M; Coyette F; Krier M; Franconie C; Bindschadler C; Diouf M; Godefroy O; J Head Trauma Rehabil; 2016; 31(3):E10-20. PubMed ID: 26394296 [TBL] [Abstract][Full Text] [Related]
4. Ecological evaluation of executive functions in mild cognitive impairment and Alzheimer disease. da Costa Armentano CG; Porto CS; Nitrini R; Dozzi Brucki SM Alzheimer Dis Assoc Disord; 2013; 27(2):95-101. PubMed ID: 22828321 [TBL] [Abstract][Full Text] [Related]
5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
6. Dysexecutive syndrome in Parkinson's disease: the GREFEX study. Roussel M; Lhommée E; Narme P; Czernecki V; Gall DL; Krystkowiak P; Diouf M; Godefroy O; Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2017 Sep; 24(5):496-507. PubMed ID: 27585478 [TBL] [Abstract][Full Text] [Related]
7. The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study. Roussel M; Martinaud O; Hénon H; Vercelletto M; Bindschadler C; Joseph PA; Robert P; Labauge P; Godefroy O; PLoS One; 2016; 11(1):e0147602. PubMed ID: 26824746 [TBL] [Abstract][Full Text] [Related]
8. Dysexecutive syndrome: diagnostic criteria and validation study. Godefroy O; Azouvi P; Robert P; Roussel M; LeGall D; Meulemans T; Ann Neurol; 2010 Dec; 68(6):855-64. PubMed ID: 21194155 [TBL] [Abstract][Full Text] [Related]
9. Patterns of executive dysfunction in amnestic mild cognitive impairment. Chen NC; Chang CC; Lin KN; Huang CW; Chang WN; Chang YT; Chen C; Yeh YC; Wang PN Int Psychogeriatr; 2013 Jul; 25(7):1181-9. PubMed ID: 23574879 [TBL] [Abstract][Full Text] [Related]
10. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577 [TBL] [Abstract][Full Text] [Related]
11. The short cognitive evaluation battery in cognitive disorders of the elderly--Italian version. Girtler N; Brugnolo A; Campus C; De Carli F; Famà F; Ghio L; Robert P; Barbieri MP; Delmonte M; Venuti S; Gabrielli F; Rodriguez G; Nobili F Dement Geriatr Cogn Disord; 2012; 33(4):255-65. PubMed ID: 22738937 [TBL] [Abstract][Full Text] [Related]
12. Differentiation between amnestic-mild cognitive impairment and early-stage Alzheimer's disease using the Frontal Assessment Battery test. Yamao A; Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kasahara H; Nakayama K Psychogeriatrics; 2011 Dec; 11(4):235-41. PubMed ID: 22151243 [TBL] [Abstract][Full Text] [Related]
13. Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): normative values from a healthy sample and clinical utility in Alzheimer's disease. Moreira HS; Lima CF; Vicente SG J Alzheimers Dis; 2014; 42(1):261-73. PubMed ID: 24840570 [TBL] [Abstract][Full Text] [Related]
14. Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia. Janelidze M; Mikeladze N; Bochorishvili N; Dzagnidze A; Kapianidze M; Mikava N; Khatiashvili I; Kakhiani D; Mirvelashvili E; Shiukashvili N; Nadareishvili Z Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):36-40. PubMed ID: 27909150 [TBL] [Abstract][Full Text] [Related]
15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
16. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease. Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954 [TBL] [Abstract][Full Text] [Related]
17. Can a tablet-based cancellation test identify cognitive impairment in older adults? Wu YH; Vidal JS; de Rotrou J; Sikkes SAM; Rigaud AS; Plichart M PLoS One; 2017; 12(7):e0181809. PubMed ID: 28742136 [TBL] [Abstract][Full Text] [Related]